Editorial Intern at Caribbean Medical Journal (2024-12 – 2025-05)
- Managed incoming manuscript submissions: logging, organizing and tracking status across concurrent submissions in a deadline-driven workflow.
- Assessed submissions for methodological rigour and compliance; escalated concerns to senior editors.
- Coordinated author-reviewer communications and maintained records of editorial decisions and publication workflow.
Upstream Process Development Scientist at Spark Therapeutics (2023-09 – 2024-05)
- Optimised rAAV gene therapy production platforms through systematic bioprocess parameter evaluation across fed-batch and perfusion modes at multiple scales.
- Authored and revised SOPs; delivered cross-training sessions on bioreactor software and equipment to internal departments.
- Led RCA and CAPA activities to identify root causes of process deviations and implement preventive measures, directly analogous to clinical quality event management.
- Contributed to the development of a Raman spectroscopy-based predictive model for real-time non-invasive metabolite and cell count monitoring in bioreactor cultures.
- Managed bioreactor consumables inventory and maintained audit-ready documentation throughout.
Cardiovascular Technician at Cardiovascular Associates Limited (2021-12 – 2022-02)
- Collected and entered structured clinical data to support physician-led patient assessment and diagnosis.
- Performed and documented EKGs, stress tests, Holter recordings, echocardiographs and bone densitometry with full clinical record maintenance.
- Maintained diagnostic equipment and ensured complete, accurate records for clinical review.
Customer Service Representative at Direcone International Contact Center (2019-03 – 2019-10)
- Entered interaction data accurately into CRM platforms; tracked request status and followed up to ensure resolution.
- Communicated with clients using established scripts; escalated unresolved issues following standard procedures.
Upstream Biomanufacturing Technician at Janssen Biotech (2024-06 – 2024-10)
- Aseptically sampled and processed daily cell counts from 110L, 500L, 1000L, and 2000L bioreactors across batch, perfusion, and single-use formats under cGMP requirements.
- Contributed to integration of new single-use bioreactor technology within upstream manufacturing suites.
- Performed SiP, CiP, and CoP activities; maintained accurate batch records and deviation logs.